Document is current

Documents that mention this clinical trial

Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation: GARFIELD-AF
https://doi.org/10.1136/openhrt-2022-002038

Comparative effectiveness of oral anticoagulants in everyday practice
https://doi.org/10.1136/heartjnl-2020-318420

Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry ^{(Pre-results)}
https://doi.org/10.1136/bmjopen-2017-018905

Emulation of ARISTOTLE and ROCKET AF trials in real-world atrial fibrillation patients results in similar efficacy and safety as original landmark trials: insights from the GARFIELD-AF registry
https://doi.org/10.1136/openhrt-2024-002966

Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data
https://doi.org/10.1136/bmj-2021-066450

Do baseline characteristics and treatments account for geographical disparities in the outcomes of patients with newly diagnosed atrial fibrillation? The prospective GARFIELD-AF registry
https://doi.org/10.1136/bmjopen-2021-049933

Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation
https://doi.org/10.1136/bmjopen-2017-017157

Atrial fibrillation outcomes in patients from Asia and non-Asia countries: insights from GARFIELD-AF
https://doi.org/10.1136/openhrt-2024-003109